Groundbreaking ceremony with Mayor Hermann Nafziger, Kerstin Schreyer, Bavarian Economic Policy Spokeswoman, District Administrator Christoph Göbel, Minister President Dr. Markus Söder, Markus Blume, State Minister for Science and the Arts, Christian Bernreiter for Housing, Construction and Transportation, Managing Director Engineering and Turnkey Construction of LEONHARD WEISS Steffen Schönfeld and PMG Managing Director Dr. Dimitri Steinke.

The extension, which was celebrated with an official groundbreaking ceremony, will connect the IZB campus in Martinsried to the Munich subway system.

Precision fermentation at Evonik. © Evonik SE

Fermatation expert Evonik SE has entered into an agreement with the German recombinant silk producer AMSilk to produce industrial quantities of innovative, sustainable silk proteins. 

T-Cell-Dendritic-Cell interaction. © Hookipa

HOOKIPA has received a US$10m milestone under its 2022 agreement with Roche to develop an arenaviral immunotherapy for KRAS-mutated cancers.

© Cydar Medical

Cambridge-based endovascular surgical AI specialist Cydar Medical has completed a €10.5m (£9.3m) Series A funding round led by Pembroke Venture Capital Trust

Rotor Print S.L. received the award for Eco design at the Innovation Awards at Pharmapack Europe for their recyclable blister. ©Pharmapack

How to make pharma packaging sustainable was one of the major discussion topics at PHARMAPACK 2023.

© Evonetix Ltd

British Evonetix Ltd has added US$$24m to its existing US$30m Series B financing round. The new financing was led by existing investor Foresite Capital.

Christian_Bo__hm.jpg

Toulouse White Biotech (TWB) is a good example to how scaling and collaboration through production partnerships can help the industrial biotech sector to satisfy the urgent need to speed up and scale sustainable processes for industrial production.

© Curevac NV

mRNA vaccine pioneer CureVac N.V. has announced that it will sell US$200m of its common shares in an underwritten public offering.

© Vetter Pharma International GmbH: Supporting efficient drug development with dedicated clinical development expertise.

Both the US Skokie and European Rankweil sites address customer needs in early-phase drug development

Picture: BioSenic

Dr Carole Nicco took up her position as CSO of Belgium-based BioSenic in mid-January. Nicco will oversee the development of BioSenic’s cell therapy and autoimmune disease platform pipeline and be responsible for R&D programmes.